Structure

Physi-Chem Properties

Molecular Weight:  534.17
Volume:  508.417
LogP:  0.947
LogD:  0.369
LogS:  -3.834
# Rotatable Bonds:  7
TPSA:  210.51
# H-Bond Aceptor:  12
# H-Bond Donor:  8
# Rings:  4
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.208
Synthetic Accessibility Score:  4.256
Fsp3:  0.423
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.227
MDCK Permeability:  1.5973062545526773e-05
Pgp-inhibitor:  0.081
Pgp-substrate:  0.718
Human Intestinal Absorption (HIA):  0.558
20% Bioavailability (F20%):  0.017
30% Bioavailability (F30%):  0.978

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.018
Plasma Protein Binding (PPB):  90.36312103271484%
Volume Distribution (VD):  0.931
Pgp-substrate:  9.434487342834473%

ADMET: Metabolism

CYP1A2-inhibitor:  0.113
CYP1A2-substrate:  0.045
CYP2C19-inhibitor:  0.013
CYP2C19-substrate:  0.054
CYP2C9-inhibitor:  0.103
CYP2C9-substrate:  0.257
CYP2D6-inhibitor:  0.081
CYP2D6-substrate:  0.147
CYP3A4-inhibitor:  0.033
CYP3A4-substrate:  0.02

ADMET: Excretion

Clearance (CL):  2.835
Half-life (T1/2):  0.87

ADMET: Toxicity

hERG Blockers:  0.072
Human Hepatotoxicity (H-HT):  0.287
Drug-inuced Liver Injury (DILI):  0.981
AMES Toxicity:  0.848
Rat Oral Acute Toxicity:  0.024
Maximum Recommended Daily Dose:  0.002
Skin Sensitization:  0.25
Carcinogencity:  0.048
Eye Corrosion:  0.003
Eye Irritation:  0.034
Respiratory Toxicity:  0.016

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC183672

Natural Product ID:  NPC183672
Common Name*:   Amurensin
IUPAC Name:   3,5-dihydroxy-8-(3-hydroxy-3-methylbutyl)-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
Synonyms:   Amurensin
Standard InCHIKey:  UNHHWEHQUUGKEE-MLLLWRCASA-N
Standard InCHI:  InChI=1S/C26H30O12/c1-26(2,35)8-7-13-15(36-25-22(34)20(32)18(30)16(10-27)37-25)9-14(29)17-19(31)21(33)23(38-24(13)17)11-3-5-12(28)6-4-11/h3-6,9,16,18,20,22,25,27-30,32-35H,7-8,10H2,1-2H3/t16-,18-,20+,22-,25-/m1/s1
SMILES:  OC[C@H]1O[C@@H](Oc2cc(O)c3c(c2CCC(O)(C)C)oc(c(c3=O)O)c2ccc(cc2)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL454069
PubChem CID:   5318156
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides
            • [CHEMONTID:0003533] Flavonoid-7-O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21349 Punica granatum Species Lythraceae Eukaryota n.a. fruit n.a. DOI[10.1007/s00217-007-0799-1]
NPO21349 Punica granatum Species Lythraceae Eukaryota n.a. flower n.a. DOI[10.1016/j.foodchem.2011.01.077]
NPO21349 Punica granatum Species Lythraceae Eukaryota n.a. n.a. n.a. PMID[11520216]
NPO24476.1 Phellodendron amurense var. wilsonii Varieties Rutaceae Eukaryota Leaves n.a. n.a. PMID[14510598]
NPO21349 Punica granatum Species Lythraceae Eukaryota Seeds n.a. n.a. PMID[15620261]
NPO21349 Punica granatum Species Lythraceae Eukaryota n.a. n.a. Database[FooDB]
NPO21349 Punica granatum Species Lythraceae Eukaryota Bark n.a. n.a. Database[FooDB]
NPO21349 Punica granatum Species Lythraceae Eukaryota Fruit n.a. n.a. Database[FooDB]
NPO21349 Punica granatum Species Lythraceae Eukaryota Leaf n.a. n.a. Database[FooDB]
NPO21349 Punica granatum Species Lythraceae Eukaryota Pericarp n.a. n.a. Database[FooDB]
NPO21349 Punica granatum Species Lythraceae Eukaryota Root Bark n.a. n.a. Database[FooDB]
NPO21349 Punica granatum Species Lythraceae Eukaryota Seed n.a. n.a. Database[FooDB]
NPO21349 Punica granatum Species Lythraceae Eukaryota Stem Bark n.a. n.a. Database[FooDB]
NPO21349 Punica granatum Species Lythraceae Eukaryota Twig n.a. n.a. Database[FooDB]
NPO21349 Punica granatum Species Lythraceae Eukaryota n.a. n.a. Database[FooDB]
NPO21349 Punica granatum Species Lythraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO24476.1 Phellodendron amurense var. wilsonii Varieties Rutaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO3690 Vitis amurensis Species Vitaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO21349 Punica granatum Species Lythraceae Eukaryota n.a. n.a. Database[Phenol-Explorer]
NPO21349 Punica granatum Species Lythraceae Eukaryota Fruits n.a. Database[Phenol-Explorer]
NPO24476.1 Phellodendron amurense var. wilsonii Varieties Rutaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21349 Punica granatum Species Lythraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3690 Vitis amurensis Species Vitaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21349 Punica granatum Species Lythraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO21349 Punica granatum Species Lythraceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO21349 Punica granatum Species Lythraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1 Others Radical scavenging activity IC50 = 88300.0 nM PMID[487745]
NPT741 Individual Protein Tyrosinase Homo sapiens Inhibition = 15.4 % PMID[487745]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC183672 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9935 High Similarity NPC131745
0.9871 High Similarity NPC179198
0.9871 High Similarity NPC278419
0.9871 High Similarity NPC66087
0.9806 High Similarity NPC259834
0.9679 High Similarity NPC44947
0.9675 High Similarity NPC108831
0.9675 High Similarity NPC182634
0.9623 High Similarity NPC5319
0.9618 High Similarity NPC257566
0.9618 High Similarity NPC124155
0.9615 High Similarity NPC47923
0.9613 High Similarity NPC41121
0.9613 High Similarity NPC320283
0.9613 High Similarity NPC111929
0.9613 High Similarity NPC472459
0.9613 High Similarity NPC73511
0.961 High Similarity NPC307938
0.961 High Similarity NPC203500
0.961 High Similarity NPC323593
0.9554 High Similarity NPC150164
0.9551 High Similarity NPC187379
0.9551 High Similarity NPC153342
0.9551 High Similarity NPC472320
0.9548 High Similarity NPC156457
0.9548 High Similarity NPC313163
0.9548 High Similarity NPC258035
0.9548 High Similarity NPC197896
0.9548 High Similarity NPC161749
0.9548 High Similarity NPC23817
0.9548 High Similarity NPC78263
0.9548 High Similarity NPC133671
0.9548 High Similarity NPC77672
0.9548 High Similarity NPC54802
0.9548 High Similarity NPC135391
0.9548 High Similarity NPC197304
0.9548 High Similarity NPC6985
0.9545 High Similarity NPC304207
0.9545 High Similarity NPC48579
0.9545 High Similarity NPC470603
0.9545 High Similarity NPC95090
0.9545 High Similarity NPC217706
0.9545 High Similarity NPC470604
0.9545 High Similarity NPC207809
0.9545 High Similarity NPC259710
0.9545 High Similarity NPC27408
0.9545 High Similarity NPC304745
0.9545 High Similarity NPC111341
0.9545 High Similarity NPC470605
0.9494 High Similarity NPC121703
0.949 High Similarity NPC116458
0.949 High Similarity NPC476215
0.949 High Similarity NPC224530
0.949 High Similarity NPC246943
0.949 High Similarity NPC265885
0.949 High Similarity NPC215710
0.949 High Similarity NPC85707
0.949 High Similarity NPC139320
0.949 High Similarity NPC216496
0.949 High Similarity NPC129217
0.949 High Similarity NPC259957
0.949 High Similarity NPC249281
0.949 High Similarity NPC303913
0.949 High Similarity NPC181465
0.949 High Similarity NPC473438
0.949 High Similarity NPC159579
0.949 High Similarity NPC48093
0.949 High Similarity NPC163242
0.949 High Similarity NPC276377
0.949 High Similarity NPC173582
0.949 High Similarity NPC253788
0.9487 High Similarity NPC470607
0.9484 High Similarity NPC206378
0.9484 High Similarity NPC45165
0.9481 High Similarity NPC108706
0.9481 High Similarity NPC78021
0.9481 High Similarity NPC87304
0.9481 High Similarity NPC143851
0.9481 High Similarity NPC211158
0.9481 High Similarity NPC29763
0.9481 High Similarity NPC210003
0.9481 High Similarity NPC180301
0.9481 High Similarity NPC106625
0.9481 High Similarity NPC248793
0.9481 High Similarity NPC268193
0.9481 High Similarity NPC83283
0.9481 High Similarity NPC268950
0.9481 High Similarity NPC39360
0.9434 High Similarity NPC72016
0.943 High Similarity NPC27942
0.943 High Similarity NPC240306
0.943 High Similarity NPC190450
0.9427 High Similarity NPC304741
0.9427 High Similarity NPC136761
0.9427 High Similarity NPC470405
0.9427 High Similarity NPC471079
0.9423 High Similarity NPC44931
0.9423 High Similarity NPC129827
0.9423 High Similarity NPC60966
0.9423 High Similarity NPC122809
0.9423 High Similarity NPC470606
0.9423 High Similarity NPC65003
0.9423 High Similarity NPC473512
0.9419 High Similarity NPC169248
0.9419 High Similarity NPC99233
0.9419 High Similarity NPC97052
0.9419 High Similarity NPC39351
0.9419 High Similarity NPC72649
0.9419 High Similarity NPC26195
0.9416 High Similarity NPC244583
0.9416 High Similarity NPC56232
0.9416 High Similarity NPC121001
0.9416 High Similarity NPC150123
0.9416 High Similarity NPC161881
0.9416 High Similarity NPC10807
0.9416 High Similarity NPC259182
0.9387 High Similarity NPC294629
0.9367 High Similarity NPC64305
0.9367 High Similarity NPC470125
0.9367 High Similarity NPC135846
0.9367 High Similarity NPC170052
0.9367 High Similarity NPC297987
0.9367 High Similarity NPC282169
0.9363 High Similarity NPC104677
0.9363 High Similarity NPC138811
0.9363 High Similarity NPC308265
0.9363 High Similarity NPC22062
0.9363 High Similarity NPC473634
0.9363 High Similarity NPC43761
0.9359 High Similarity NPC261866
0.9359 High Similarity NPC127406
0.9359 High Similarity NPC20530
0.9359 High Similarity NPC170475
0.9359 High Similarity NPC10754
0.9359 High Similarity NPC17521
0.9359 High Similarity NPC215917
0.9355 High Similarity NPC236756
0.9355 High Similarity NPC223701
0.9355 High Similarity NPC7989
0.9355 High Similarity NPC311579
0.9355 High Similarity NPC472583
0.9351 High Similarity NPC319910
0.9351 High Similarity NPC328740
0.9351 High Similarity NPC209846
0.9351 High Similarity NPC262038
0.9351 High Similarity NPC278476
0.9351 High Similarity NPC262039
0.9351 High Similarity NPC477897
0.9351 High Similarity NPC289774
0.9351 High Similarity NPC254412
0.9321 High Similarity NPC78734
0.9321 High Similarity NPC76047
0.9321 High Similarity NPC150767
0.9317 High Similarity NPC173637
0.9317 High Similarity NPC127546
0.9317 High Similarity NPC52550
0.9317 High Similarity NPC84362
0.9317 High Similarity NPC317489
0.9317 High Similarity NPC223424
0.9313 High Similarity NPC135358
0.9313 High Similarity NPC139060
0.9313 High Similarity NPC277205
0.9313 High Similarity NPC287889
0.9308 High Similarity NPC93215
0.9304 High Similarity NPC200708
0.9304 High Similarity NPC142860
0.9304 High Similarity NPC246469
0.9304 High Similarity NPC271270
0.9304 High Similarity NPC97285
0.9304 High Similarity NPC473623
0.9304 High Similarity NPC306978
0.9304 High Similarity NPC271479
0.9299 High Similarity NPC210048
0.9299 High Similarity NPC288084
0.9299 High Similarity NPC43638
0.9295 High Similarity NPC476169
0.9295 High Similarity NPC92395
0.9295 High Similarity NPC470681
0.9295 High Similarity NPC87404
0.929 High Similarity NPC475790
0.929 High Similarity NPC88484
0.929 High Similarity NPC243171
0.929 High Similarity NPC259767
0.929 High Similarity NPC138288
0.929 High Similarity NPC217149
0.929 High Similarity NPC216035
0.929 High Similarity NPC35567
0.929 High Similarity NPC171651
0.9286 High Similarity NPC105136
0.9286 High Similarity NPC191154
0.9286 High Similarity NPC38775
0.9273 High Similarity NPC168584
0.9268 High Similarity NPC108202
0.9264 High Similarity NPC245452
0.9264 High Similarity NPC256760
0.9259 High Similarity NPC52382
0.9259 High Similarity NPC259905
0.9259 High Similarity NPC219904
0.9259 High Similarity NPC120099
0.9259 High Similarity NPC203050

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC183672 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9623 High Similarity NPD7804 Clinical (unspecified phase)
0.9548 High Similarity NPD4381 Clinical (unspecified phase)
0.9161 High Similarity NPD4380 Phase 2
0.9146 High Similarity NPD6797 Phase 2
0.9091 High Similarity NPD7251 Discontinued
0.9057 High Similarity NPD7075 Discontinued
0.9036 High Similarity NPD7808 Phase 3
0.9024 High Similarity NPD7054 Approved
0.897 High Similarity NPD7472 Approved
0.897 High Similarity NPD7074 Phase 3
0.8961 High Similarity NPD4378 Clinical (unspecified phase)
0.8924 High Similarity NPD6801 Discontinued
0.8922 High Similarity NPD4338 Clinical (unspecified phase)
0.8868 High Similarity NPD7096 Clinical (unspecified phase)
0.8848 High Similarity NPD3818 Discontinued
0.875 High Similarity NPD6559 Discontinued
0.875 High Similarity NPD2393 Clinical (unspecified phase)
0.8727 High Similarity NPD6166 Phase 2
0.8727 High Similarity NPD6168 Clinical (unspecified phase)
0.8727 High Similarity NPD6167 Clinical (unspecified phase)
0.8599 High Similarity NPD7410 Clinical (unspecified phase)
0.858 High Similarity NPD8443 Clinical (unspecified phase)
0.8571 High Similarity NPD1934 Approved
0.8509 High Similarity NPD7411 Suspended
0.8506 High Similarity NPD1550 Clinical (unspecified phase)
0.8506 High Similarity NPD1552 Clinical (unspecified phase)
0.8491 Intermediate Similarity NPD5403 Approved
0.8466 Intermediate Similarity NPD3817 Phase 2
0.8452 Intermediate Similarity NPD1549 Phase 2
0.8418 Intermediate Similarity NPD6799 Approved
0.8409 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8365 Intermediate Similarity NPD5401 Approved
0.8354 Intermediate Similarity NPD5402 Approved
0.8323 Intermediate Similarity NPD2796 Approved
0.8313 Intermediate Similarity NPD1512 Approved
0.8293 Intermediate Similarity NPD2801 Approved
0.8293 Intermediate Similarity NPD7819 Suspended
0.8258 Intermediate Similarity NPD1510 Phase 2
0.8221 Intermediate Similarity NPD6599 Discontinued
0.8216 Intermediate Similarity NPD7584 Approved
0.8214 Intermediate Similarity NPD6959 Discontinued
0.8193 Intermediate Similarity NPD3882 Suspended
0.8193 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD1511 Approved
0.8176 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8087 Intermediate Similarity NPD6782 Approved
0.8087 Intermediate Similarity NPD6780 Approved
0.8087 Intermediate Similarity NPD6781 Approved
0.8087 Intermediate Similarity NPD6776 Approved
0.8087 Intermediate Similarity NPD6778 Approved
0.8087 Intermediate Similarity NPD6777 Approved
0.8087 Intermediate Similarity NPD6779 Approved
0.8047 Intermediate Similarity NPD5494 Approved
0.8046 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8011 Intermediate Similarity NPD8313 Approved
0.8011 Intermediate Similarity NPD8312 Approved
0.8 Intermediate Similarity NPD1240 Approved
0.7977 Intermediate Similarity NPD3751 Discontinued
0.7976 Intermediate Similarity NPD7768 Phase 2
0.7964 Intermediate Similarity NPD8455 Phase 2
0.7957 Intermediate Similarity NPD7435 Discontinued
0.7953 Intermediate Similarity NPD3787 Discontinued
0.7931 Intermediate Similarity NPD5844 Phase 1
0.7923 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD1607 Approved
0.7888 Intermediate Similarity NPD3750 Approved
0.7888 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7861 Intermediate Similarity NPD7696 Phase 3
0.7861 Intermediate Similarity NPD7698 Approved
0.7861 Intermediate Similarity NPD7697 Approved
0.7849 Intermediate Similarity NPD6232 Discontinued
0.7826 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7824 Intermediate Similarity NPD3749 Approved
0.7819 Intermediate Similarity NPD7870 Phase 2
0.7819 Intermediate Similarity NPD7871 Phase 2
0.7816 Intermediate Similarity NPD7473 Discontinued
0.7814 Intermediate Similarity NPD6534 Approved
0.7814 Intermediate Similarity NPD6535 Approved
0.7789 Intermediate Similarity NPD7701 Phase 2
0.7789 Intermediate Similarity NPD7585 Approved
0.7778 Intermediate Similarity NPD4628 Phase 3
0.7737 Intermediate Similarity NPD7583 Approved
0.7716 Intermediate Similarity NPD2800 Approved
0.7711 Intermediate Similarity NPD920 Approved
0.7708 Intermediate Similarity NPD7874 Approved
0.7708 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD7699 Phase 2
0.7688 Intermediate Similarity NPD7700 Phase 2
0.7674 Intermediate Similarity NPD919 Approved
0.7668 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7668 Intermediate Similarity NPD7783 Phase 2
0.7668 Intermediate Similarity NPD7801 Approved
0.7665 Intermediate Similarity NPD1653 Approved
0.7656 Intermediate Similarity NPD8151 Discontinued
0.7654 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD2935 Discontinued
0.764 Intermediate Similarity NPD1551 Phase 2
0.764 Intermediate Similarity NPD5953 Discontinued
0.7624 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD4360 Phase 2
0.7622 Intermediate Similarity NPD4363 Phase 3
0.7619 Intermediate Similarity NPD7458 Discontinued
0.7619 Intermediate Similarity NPD6823 Phase 2
0.761 Intermediate Similarity NPD5124 Phase 1
0.761 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7607 Intermediate Similarity NPD1243 Approved
0.7605 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7598 Intermediate Similarity NPD7685 Pre-registration
0.759 Intermediate Similarity NPD2532 Approved
0.759 Intermediate Similarity NPD2533 Approved
0.759 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.759 Intermediate Similarity NPD2534 Approved
0.7586 Intermediate Similarity NPD1247 Approved
0.7586 Intermediate Similarity NPD7199 Phase 2
0.7578 Intermediate Similarity NPD7033 Discontinued
0.7578 Intermediate Similarity NPD3748 Approved
0.7576 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD7228 Approved
0.7562 Intermediate Similarity NPD6651 Approved
0.7544 Intermediate Similarity NPD1465 Phase 2
0.7539 Intermediate Similarity NPD8320 Phase 1
0.7539 Intermediate Similarity NPD8319 Approved
0.7532 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD2313 Discontinued
0.7528 Intermediate Similarity NPD7286 Phase 2
0.75 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD8434 Phase 2
0.7486 Intermediate Similarity NPD8150 Discontinued
0.7485 Intermediate Similarity NPD37 Approved
0.7471 Intermediate Similarity NPD6234 Discontinued
0.7469 Intermediate Similarity NPD2799 Discontinued
0.7457 Intermediate Similarity NPD4967 Phase 2
0.7457 Intermediate Similarity NPD4966 Approved
0.7457 Intermediate Similarity NPD4965 Approved
0.7438 Intermediate Similarity NPD1613 Approved
0.7438 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD6798 Discontinued
0.7412 Intermediate Similarity NPD3226 Approved
0.7405 Intermediate Similarity NPD4908 Phase 1
0.7403 Intermediate Similarity NPD1091 Approved
0.7401 Intermediate Similarity NPD3926 Phase 2
0.7391 Intermediate Similarity NPD1933 Approved
0.7389 Intermediate Similarity NPD2798 Approved
0.736 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD2424 Discontinued
0.7327 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD7390 Discontinued
0.7317 Intermediate Similarity NPD6100 Approved
0.7317 Intermediate Similarity NPD6099 Approved
0.7305 Intermediate Similarity NPD6190 Approved
0.7296 Intermediate Similarity NPD6832 Phase 2
0.729 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD1652 Phase 2
0.7287 Intermediate Similarity NPD6212 Phase 3
0.7287 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7287 Intermediate Similarity NPD6213 Phase 3
0.7284 Intermediate Similarity NPD6355 Discontinued
0.7278 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7266 Discontinued
0.7273 Intermediate Similarity NPD2344 Approved
0.7273 Intermediate Similarity NPD2346 Discontinued
0.7267 Intermediate Similarity NPD6233 Phase 2
0.7246 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7231 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD943 Approved
0.7215 Intermediate Similarity NPD1203 Approved
0.7213 Intermediate Similarity NPD7240 Approved
0.7211 Intermediate Similarity NPD4361 Phase 2
0.7211 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD3268 Approved
0.72 Intermediate Similarity NPD7930 Approved
0.7195 Intermediate Similarity NPD7097 Phase 1
0.7188 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD1610 Phase 2
0.716 Intermediate Similarity NPD5058 Phase 3
0.7158 Intermediate Similarity NPD3823 Discontinued
0.7152 Intermediate Similarity NPD4308 Phase 3
0.7152 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD5710 Approved
0.7151 Intermediate Similarity NPD5711 Approved
0.715 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD3027 Phase 3
0.7143 Intermediate Similarity NPD1548 Phase 1
0.7135 Intermediate Similarity NPD5049 Phase 3
0.7125 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD4060 Phase 1
0.7107 Intermediate Similarity NPD2797 Approved
0.7101 Intermediate Similarity NPD3887 Approved
0.7101 Intermediate Similarity NPD2309 Approved
0.7101 Intermediate Similarity NPD2354 Approved
0.7086 Intermediate Similarity NPD6844 Discontinued
0.7083 Intermediate Similarity NPD6674 Discontinued
0.7073 Intermediate Similarity NPD230 Phase 1
0.7072 Intermediate Similarity NPD2403 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data